Literature DB >> 21078931

Human tissue distribution of voriconazole.

Stefan Weiler1, David Fiegl, Róisín MacFarland, Eva Stienecke, Rosa Bellmann-Weiler, Stefan Dunzendorfer, Michael Joannidis, Romuald Bellmann.   

Abstract

Voriconazole concentrations were determined in autopsy samples of eight patients who had been treated for a median of 7 days (interquartile range [IQR], 5 days). Voriconazole penetrates well into various tissues, with median levels of 6.26 μg/g ((interquartile range [IQR], 7.87 μg/g) in the lung, 3.41 μg/g (IQR, 16.72 μg/g) in the brain, 6.89 μg/g (IQR, 24.16 μg/g) in the liver, 6.47 μg/g (IQR, 6.19 μg/g) in the kidneys, 5.60 μg/g (IQR, 11.49 μg/g) in the spleen, and 7.55 μg/g (IQR, 16.91 μg/g) in the myocardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078931      PMCID: PMC3028808          DOI: 10.1128/AAC.00949-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Authors:  Jean-Baptiste Stern; Philippe Girard; Raffaele Caliandro
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

3.  Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.

Authors:  GholamAli Khoschsorur; Franz Fruehwirth; Sieglinde Zelzer
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion.

Authors:  Helene Vogelsinger; Stefan Weiler; Angela Djanani; Jordan Kountchev; Rosa Bellmann-Weiler; Christian J Wiedermann; Romuald Bellmann
Journal:  J Antimicrob Chemother       Date:  2006-04-20       Impact factor: 5.790

5.  Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.

Authors:  J C Poupelin; F Philit; J C Richard; M Badet; S Lemasson; F Bayle; C Guérin
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

6.  Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.

Authors:  Blair Capitano; Brian A Potoski; Shahid Husain; Shimin Zhang; David L Paterson; Sean M Studer; Kenneth R McCurry; Raman Venkataramanan
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

7.  Voriconazole therapeutic drug monitoring.

Authors:  J Smith; N Safdar; V Knasinski; W Simmons; S M Bhavnani; P G Ambrose; D Andes
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes.

Authors:  Sofía Ballesta; Isabel García; Evelio J Perea; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2005-04-11       Impact factor: 5.790

9.  Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.

Authors:  Thomas Elter; Michal Sieniawski; Axel Gossmann; Claudia Wickenhauser; Ursula Schröder; Harald Seifert; Johannes Kuchta; Jürgen Burhenne; Klaus-Dieter Riedel; Gerd Fätkenheuer; Oliver A Cornely
Journal:  Int J Antimicrob Agents       Date:  2006-09       Impact factor: 5.283

10.  Fluconazole penetration in cerebral parenchyma in humans at steady state.

Authors:  F Thaler; B Bernard; M Tod; C P Jedynak; O Petitjean; P Derome; P Loirat
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

View more
  15 in total

Review 1.  [Strategies for antifungal treatment failure in intensive care units].

Authors:  C Arens; M Bernhard; C Koch; A Heininger; D Störzinger; T Hoppe-Tichy; M Hecker; B Grabein; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

Review 2.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 3.  Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.

Authors:  H B Liu; F Liu; Q T Kong; Y N Shen; G X Lv; W D Liu; H Sang
Journal:  Mycopathologia       Date:  2015-06-05       Impact factor: 2.574

4.  Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.

Authors:  Woo J Moon; Erica L Scheller; Anupam Suneja; Jacob A Livermore; Anurag N Malani; Varsha Moudgal; Lisa E Kerr; Eric Ferguson; David M Vandenberg
Journal:  Clin Infect Dis       Date:  2014-07-03       Impact factor: 9.079

5.  A physiologically based pharmacokinetic model for voriconazole disposition predicts intestinal first-pass metabolism in children.

Authors:  Nicole R Zane; Dhiren R Thakker
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

6.  Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.

Authors:  Michael E Henry; Nicolas R Bolo; Chun S Zuo; Rosemond A Villafuerte; Kenroy Cayetano; Paul Glue; Bharat D Damle; Emma Andrews; Tara L Lauriat; Namoode S Rana; Jeffrey H Churchill; Perry F Renshaw
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

Review 7.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

8.  Human Tissue Distribution of Anidulafungin and Micafungin.

Authors:  Jana Marx; René Welte; Tiziana Gasperetti; Patrizia Moser; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

9.  Candida albicans brain abscesses in an injection drug user patient: a case report.

Authors:  Nélia Neves; Lurdes Santos; Carina Reis; António Sarmento
Journal:  BMC Res Notes       Date:  2014-11-25

Review 10.  Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.

Authors:  Julie Autmizguine; Jeffrey T Guptill; Michael Cohen-Wolkowiez; Daniel K Benjamin; Edmund V Capparelli
Journal:  Drugs       Date:  2014-06       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.